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Abstract: Analysing wastewater samples is an innovative approach that overcomes 12 
many limitations of traditional surveys to identify and measure a range of chemicals 13 
that were consumed by or exposed to people living in a sewer catchment area. First 14 
conceptualised in 2001, much progress has been made to make wastewater analysis 15 
(WWA) a reliable and robust tool for measuring chemical consumption and or 16 
exposure. At the moment, the most popular application of WWA, sometimes referred 17 
as sewage epidemiology, is to monitor the consumption of illicit drugs in 18 
communities around the globe, including China. The approach has been largely 19 
adopted by law enforcement agencies as a device to monitor the temporal and 20 
geographical pattern of drug consumption. In the future, the methodology can be 21 
extended to other chemicals including biomarkers of population health (e.g. 22 
environmental or oxidative stress biomarkers, lifestyle indicators or medications that 23 
are taken by different demographic groups) and pollutants that people are exposed to 24 
(e.g. polycyclic aromatic hydrocarbons, perfluorinated chemicals, and toxic 25 
pesticides). The extension of WWA to a huge range of chemicals may give rise to a 26 
field called sewage chemical-information mining (SCIM) with unexplored potentials. 27 
China has many densely populated cities with thousands of sewage treatment plants 28 
which are favourable for applying WWA/SCIM in order to help relevant authorities 29 
gather information about illicit drug consumption and population health status. 30 
However, there are some prerequisites and uncertainties of the methodology that 31 
should be addressed for SCIM to reach its full potential in China.  32 
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 36 
Introduction 37 
Wastewater analysis (WWA) or Sewage epidemiology was first proposed to estimate 38 
drug consumption by US EPA environmental scientist Daughton in 2001 (Daughton, 39 
2001). The approach was based on the assumption that when particular drugs are 40 
consumed, the active parent compounds and its metabolites are excreted through urine 41 
and faeces into the sewer system, and thus enter the sewage treatment plants (STPs). 42 
By measuring levels of target parent compounds and/or metabolites, back-estimation 43 
of drug use in the population of a STP catchment area could be realised. Compared 44 
with conventional methods such as questionnaires and socio-epidemiological surveys 45 
including crime statistics, medical records, drug production and seizure rates, WWA 46 
has the advantage of providing objective, continuous, near real-time estimates of drug 47 
consumption in the population (van Nuijs et al., 2011a). Additionally, using WWA to 48 
estimate illicit drug consumption can overcome ethical issues associated with some 49 
other methods (Hall et al., 2012; Khan et al., 2014).  50 
A lot of effort has been made to improve all aspects of WWA. These include 51 
sampling protocol development to get representative samples, developing robust, 52 
sensitive analytical methods and more recently normalizing chemical loads to per 53 
capita estimates that allows more accurate comparisons between different cities and 54 
even countries (Ort et al., 2010a; Ort et al., 2010c; Zuccato et al., 2011; Zuccato et al., 55 
2005, O’Brien et al., 2014). Many researchers from a wide range of fields including 56 
but not limited to analytical chemistry, environmental science, epidemiology, forensic 57 
science, sociology and statistics from all over the world have joined the ‘WWA 58 
research community’ to improve the innovative approach during the past years. This 59 
is evident by a series of conferences organised by the European Monitoring Centre for 60 
Drug and Drug Addiction called Testing the waters starting in May 2013 in Lisbon, 61 
Portugal and the next session is planned for 2015 in Ascona, Switzerland. 62 
This review article attempted to present a brief overview of the development of WWA 63 
to date with a focus on its successful application to estimate illicit drug consumption 64 
and the future applicability of this approach in China. 65 
1. Current state of WWA 66 
1.1 Application of WWA in estimating illicit drug consumption 67 
The approach of WWA was applied for the first time in Italy in 2005 (Zuccato et al., 68 
2005) and was soon applied in several other cities in Europe and the US (van Nuijs et 69 
al., 2011a). Since then WWA has been applied to monitor the use of the classical 70 
illicit drugs such as cocaine, heroin, amphetamines and cannabis (Thomas et al., 2012; 71 
van Nuijs et al., 2011a) and more recently to identify the use of new psychoactive 72 
substances (Reid et al., 2014; van Nuijs et al., 2014).  73 
Reports of illicit drugs estimated by WWA have come from multiple countries 74 
including Australia, Belgium, Canada, Croatia, Finland, France, Italy, Ireland, The 75 
Netherlands, Sweden, the UK and the US. Estimation of illicit drug use has been 76 
performed not only in small communities such as prisons (Postigo et al., 2011), and 77 
recreational regions (Lai et al., 2012), but also in large cities like Paris and Hong 78 
Kong (Karolak et al., 2010; Lai et al., 2013). Most obtained results are in agreement 79 
with data from traditional socio-epidemiological surveys, however some 80 
underestimation and/or overestimation has been identified for some particular drug(s) 81 
(Baker et al., 2014). Thomas et al. (2012) conducted a comparison of illicit drug 82 
consumptions in 19 cities across Europe through WWA and identified distinct 83 
temporal and spatial differences in drug consumption between these cities during a 84 
single week of sampling in 2011. In 2013, Nefau et al. (2013) studied the presence of 85 
17 illicit drugs both in influent and effluent sewage from 25 French STPs. 86 
Consumption maps were drawn for cocaine, opiates, cannabis and amphetamine-like 87 
compounds. Significant geographical differences were observed which highlighted 88 
that drug consumption within a country might not be homogeneous. Similarly, Khan 89 
et al (2014) applied WWA to evaluate the use of 10 illicit drugs in 4 megacities in 90 
China and found different consumption patterns between north and south China. At 91 
the same time, Li et al. (2014) also reported the use of amphetamines across a range 92 
of communities in the metropolitan area of Beijing. A summary of WWA applications 93 
for assessing illicit drug consumption worldwide is shown in Table 1.  94 
 95 
1.2 Exploration in other areas 96 
In addition to illicit drugs, there are some initial attempts to estimate the use of 97 
alcohol and tobacco, the two most common substances that have potential to 98 
negatively impact population health and cause several social problems such as crime 99 
and injuries. Reid et al conducted the first study to estimate the use of alcohol in Oslo, 100 
Norway using WWA (Reid et al., 2011) where the highest consumption of the alcohol 101 
was observed during weekends. Sixty one percent of weekly alcohol consumption was 102 
reported on Friday and Saturday alone. Over the last year, two studies were carried 103 
out to estimate the total amount of tobacco use (nicotine consumption) in different 104 
communities through WWA (Castiglioni et al., 2014; Lopes et al., 2014). The 105 
findings produced by WWA were in close agreement with survey data and can 106 
differentiate the level of tobacco consumption among different populations. 107 
In addition to monitoring common substances of abuse (illicit drugs, alcohol, and 108 
tobacco), WWA can be considered as Sewage chemical-information mining (SCIM). 109 
In a broader sense, because the interpretation of acquired information from WWA can 110 
measure a vast amount of chemicals, WWA can provide a variety of information 111 
about the population living in a particular STP catchment. It could also be used as a 112 
powerful tool to evaluate community-wide human health with isoprostanes (stress 113 
biomarkers) already proposed by Daughton as ideal candidates (Daughton, 2012b). 114 
Daughton also conceptualized an approach to estimate the real-time population size in 115 
the sewer catchment using coprostanol as a population biomarker (Daughton, 2012a) 116 
although further study should be conducted to validate the applicability of coprostanol 117 
in WWA (Chen et al., 2014).  118 
Venkatesan and Halden have applied SCIM to forecast ecological and human health 119 
risks of manmade chemicals by analysing sewage sludge instead of wastewater for 120 
persistent organic pollutants (POPs) which are non-polar and thus less likely to be in 121 
the wastewater itself (Venkatesan and Halden, 2014). The result revealed 70% 122 
agreement between WWA and biological specimens’ analysis, and suggested that 123 
analysing sewage sludge can inform human health risk assessments by providing real-124 
time information on toxic exposures in human populations and associated body 125 
burdens of harmful, accumulative, environmental pollutants. More outcomes could be 126 
achieved if the efforts across several disciplines including clinical chemistry, 127 
environmental chemistry, environmental science, medicine and microbiology, and 128 
were combined. With continuous improvement of the method, SCIM appears a 129 
feasible and effective tool to identify the connection between population health and 130 
chemical consumption and/or exposure and thus enabling better protection of the 131 
population from such hazards.   132 
1.3 Current research to improve the methodology  133 
Current research mostly focuses on evaluating and minimizing uncertainties of the 134 
whole WWA procedure such as collecting representative sewage samples, simplifying 135 
sample pre-treatment, selecting suitable biomarkers in terms of sensitivity and 136 
stability, optimizing instrumental analysis, and refining the back calculation of results. 137 
Castiglioni et al. integrally addressed uncertainties associated with all the steps 138 
necessary to estimate community drug consumption through WWA (Castiglioni et al., 139 
2013). Using data gathered from 12 laboratories, the uncertainties can range from 5–140 
10% for sampling to 1–34% for replicated chemical analysis and 26% for back-141 
calculation of cocaine use. But the highest uncertainty comes from the estimation of 142 
population size, which varied from 7 to 55%. Based on this study, the authors also 143 
suggested a best practice protocol to minimize the overall uncertainties of the entire 144 
procedure (Castiglioni et al., 2013).  145 
Several studies have attempted to address individual issues facing WWA. For instance, 146 
Martínez Bueno et al. developed a solvent-free method for simultaneous identification 147 
and quantification of 22 illicit drugs by liquid chromatography coupled to tandem 148 
mass spectrometry (LC-MS/MS), which is deemed to be a good technique for WWA 149 
due to its simplicity, cost-effectiveness and lower environmental footprint (Martínez 150 
Bueno et al., 2011). Meanwhile, Baker and Kasprzyk-Hordern evaluated the 151 
commonly used methodologies for sample collection, storage and preparation for 152 
SCIM with solid-phase extraction (SPE) and LC-MS/MS analysis (Baker and 153 
Kasprzyk-Hordern, 2011). They concluded that from the perspective of stability, 154 
composite samples are unsuitable with regards to certain compounds like heroin and 155 
6-acetylmorphine; these two drugs reported a decrease in stability of 66% and 26% 156 
respectively after 12 hours in raw sewage at 2℃. Baker and Kasprzy-Hordern also 157 
emphasised that more rigorous reporting of method validation data are needed as 158 
underreported parameters might have major impacts on the overall performance.  159 
For the estimation of consumed drug masses in the catchment using the optimum 160 
sampling method as outlined by Ort et al. (2010b) and common chemical analysis, Lai 161 
et al. calculated the overall uncertainty to be in the range of 20-30% (relative standard 162 
deviation, RSD) (Lai et al., 2011). Lai et al. also suggested using chemicals of 163 
relatively high use in the population as a basis to estimate the population size. To 164 
further address this issue, O’Brien et al. have screened wastewater samples and found 165 
14 chemicals which could be use as real-time population markers. They then 166 
developed a model to estimate the population contributing to the sewage influents 167 
based on the load of those chemicals. Through calibrating their model with mass loads 168 
of 14 chemicals with accurate population counts (the samples were taken on Census 169 
day), they found that relatively accurate population sizes can be estimated for 170 
catchment >100,000 people (O'Brien et al., 2014). 171 
2 General procedure of WWA  172 
WWA is generally carried out using the procedure shown below (Fig. 1). 173 
Simplification and standardization of the method as well as improvement of the 174 
accuracy and reliability of the final estimates are crucial in promoting WWA for 175 
routine monitoring. 176 
2.1 Pre-investigation 177 
A systematic and comprehensive pre-investigation about the catchment area and STP 178 
under investigation is critical for reliable and accurate WWA estimates. Socio-179 
economic conditions of the study area, contemporary and historical environmental 180 
monitoring data, population size and mobility in and out of the STP catchment area, 181 
and crime statistics should all be put into consideration to achieve reliable results. The 182 
investigation could be carried out through multiple approaches such as literature 183 
reviews, visiting and surveying STPs, discussions with local authorities such as law 184 
enforcement officers, relevant medical staff as well as environmental officers, local 185 
and national councillors etc. The pre-investigation may strengthen the results’ 186 
reliability of WWA studies particularly where drug consumption estimates are the 187 
goal. These alternate methods for assessing community drug consumption are not 188 
limited to the pre-investigation stage but are also may be relevant to reconsider during 189 
or even post the sampling period. Examples of this include combining drug seizure 190 
data with loads in the wastewater and assessing the scale of the market based on the 191 
mass load of drugs removed.  192 
2.2 Sampling 193 
Samples are taken from the inlets of STPs since the influent can be regarded as a 194 
pooled urine sample (although diluted and contaminated) from a large population 195 
before it is altered by different treatment processes in the STPs. However, in addition 196 
to sewage influent, activated sludge from the aerobic or anaerobic tanks has also been 197 
used as samples for WWA (Venkatesan and Halden, 2014).  198 
For sample volume, one litre is the most common. However, sample volumes from 199 
0.05 to 10 litres have been reported. A variety of sampling methods have also been 200 
studied. Continuous flow, volume and time proportional sampling with 201 
commercialized auto-samplers have all been used in different studies. Grab samples 202 
have also been used in several studies (Hummel D, 2006). Ort et al. (2010b) found 203 
continuous flow proportional samples collected over a 24 hour period as the optimum 204 
sampling method as these are more representative of a whole day and are better at 205 
capturing events. Samples from weekdays, weekends and public holidays across the 206 
whole year have all been investigated to reveal temporal patterns of drug consumption.   207 
While it is possible for each research group to establish a continuous flow 208 
proportional sampling system, there is a need for the development of a commercial 209 
auto-sampler that use this optimal sampling method. This would allow for a 210 
standardized sampling approach for WWA while sampling at the different STPs (Ort 211 
et al., 2010b).  212 
Detailed discussion about sampling practices for wastewater has been conducted and 213 
a comprehensive sampling guide with the aim of reducing uncertainties has been 214 
proposed (Ort et al., 2010c). Evaluation of flow measurement, choice of sampling 215 
mode, determination of frequency and location have all been discussed in the 216 
abovementioned paper. For long-term routine monitoring, on-line auto-samplers are 217 
essential for representative sampling with reliability, efficiency and from economic 218 
aspects. More research should be conducted to evaluate uncertainties brought by 219 
different sampling parameters in the future.  220 
2.3 Biomarker selection 221 
Selection of suitable biomarkers is an important factor for WWA. There are several 222 
criteria for appropriate WWA biomarkers as suggested by Daughton (Daughton, 223 
2012b) including: produced exclusively by humans (i.e., not introduced by unrelated, 224 
exogenous mechanisms, e.g. illicit drug discharge), excreted in sufficient quantities 225 
(to allow detection in sewage), sufficiently stable in the sewer pipeline, amenable to 226 
cost-effective, reproducible analysis, and for several health status biomarkers they 227 
should be excreted at elevated levels under “stressed condition” significantly different 228 
to the baseline range of the chemicals excreted under “normal condition” .  229 
While biomarkers have been one of the most popular research topics in clinical 230 
science in the past decades, there were limited studies on biomarkers that can be used 231 
in WWA. As suggested by Daughton, one should start at the list of common clinical 232 
biomarkers and test them against the appropriate criteria (Daughton, 2012b). One of 233 
the criteria that has been tested in several studies is the stability of the biomarkers in 234 
the wastewater matrix and under sewer conditions. Until recently, most parent 235 
compounds and metabolites were used as biomarkers in WWA for monitoring of 236 
illicit drug consumption with the assumption that they were stable in the sewer system. 237 
But some of these biomarkers (such as cocaine or 6 acetyl morphine) are quite 238 
unstable (Thai et al., 2014; van Nuijs et al., 2012) which means that previous studies 239 
may have underestimated the amount of drugs consumed in certain catchments. To 240 
address this, excretion profiles of biomarkers including parent to metabolite ratio 241 
should be further investigated by pharmacologists, biochemists and sewer engineers 242 
to get a better grasp of consumed load versus measured load within wastewater.  243 
For WWA to reach its’ full potential, more biomarkers should be identified and tested 244 
against all of Daughton’s proposed criteria to expand the WWA application to 245 
evaluate other markers of population health, real-time population size estimation, 246 
pollutant exposure, and promote WWA as  a routine monitoring approach in STPs. 247 
2.4 Pre-treatment 248 
Filtration or centrifugation of the collected sample is essential to remove solids in the 249 
sample. However, this step may cause loss of certain analytes due to substantial 250 
affinity for particulate for some chemicals (Baker and Kasprzyk-Hordern, 2011; 251 
Plo´sz et al., 2013). Adding isotope labelled internal standards before filtration or 252 
centrifugation is an effective approach to evaluate and minimize these uncertainties. 253 
Full and accurate understanding about biomarker absorption kinetics is also useful to 254 
minimize the uncertainties associated with correction factors for the back calculation 255 
process. 256 
The observed concentrations of target compounds and their metabolites in raw sewage 257 
are often at the level of ng/L or even lower and thus pre-concentration is required. In 258 
most cases solid-phase extraction (SPE) is conducted prior to LC-MS/MS analysis in 259 
order to concentrate and remove matrix interferences from the samples.  260 
Baker and Kasprzyk-Hordern have critically evaluated the whole sample preparation 261 
process from sample collection to storage and preparation for analysis. This was 262 
conducted for both pharmaceuticals and illicit drugs in surface water and wastewater 263 
using SPE-LC-MS/MS techniques (Baker and Kasprzyk-Hordern, 2011). The study 264 
showed that uncertainties associated with biomarker degradation can be minimized if 265 
proper pre-treatment is applied. The current optimal method is to collect samples in a 266 
refrigerated (4℃) container, subsample them, acidify with hydrochloric acid and then 267 
either refrigerate at 4℃ in the dark or freeze if the samples are to be analysed at a later 268 
date to minimize biotransformation/degradation of the biomarkers. Degradation of 269 
illicit drugs and metabolites in wastewater has been evaluated by van Nuijs et al 270 
(2012). They concluded that most parent compounds and metabolites of illicit drugs 271 
such as amphetamine, methamphetamine, ecstasy and EDDP are considerably stable 272 
for 12 hours or longer, however some drugs such as cocaine and ecgonine methylester 273 
showed a clear decrease in concentration over this period. 274 
Since the SPE process is costly, time consuming and requires larger sample volumes, 275 
simpler procedures are starting to be developed. Berset et al developed a large volume 276 
direct injection method for the simultaneous analysis of licit and illicit drugs in 277 
surface water and waste water (Berset et al., 2010). It should be noted that analytical 278 
instruments are becoming more sensitive and when combined with the development 279 
of optimised methods, it seems plausible that reliable methods for analysing illicit 280 
drugs in wastewater with acceptable limits of detection (LOD) without the need for 281 
SPE is possible. This would then enhance the argument for routine WWA monitoring 282 
as a tool for measuring drug consumption. The improved sensitivity of some 283 
instruments (i.e. LC-MS/MS) is already adequate for determination of numerous 284 
chemicals in wastewater using simple pre-treatment technique such as acidifying and 285 
filtering only (e.g. the pharmaceuticals in O’Brien et al., 2014).  286 
2.5 Instrumental Analysis 287 
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is used 288 
in almost all WWA studies due to its high sensitivity, versatility and selectivity. A 289 
variety of mass spectrometers have been used in different WWA studies (Castiglioni 290 
et al., 2011). These include triple quadrupole mass spectrometer (QqQ), Orbitrap, and 291 
quadrupole time-of-flight mass spectrometers (QTOF). Most applications use QqQ 292 
since it provides better selectivity and thus can achieve low detection limits. For some 293 
compounds the use of QqQ may eliminate the need for sample extraction and clean-294 
up by using direct-injection technique (Trenholm and Snyder, 2011). Since QTOF and 295 
linear ion trap fourier transform (LIT-FT) have higher mass resolution and mass 296 
accuracy than QqQ, they can be better choices for drug identification and new 297 
synthetic drug screening in samples with complex matrix (de Voogt et al., 2011; 298 
Hernández et al., 2011).  299 
Multiple reaction monitoring (MRM) mode is used for both qualification and 300 
quantification. Several studies grouped illicit drugs according to their 301 
physicochemical properties and different analytical parameters (such as 302 
chromatography and ionization mode) in order to achieve optimum separation and the 303 
highest MS resolution. As newer, more sensitive LC-MS/MS, QTOF and Orbitrap 304 
instruments are developed, it is expected that these will have a significant role in 305 
WWA applications for their incomparable advantages in rapid wide-scope screening 306 
and providing accurate mass data of both parent molecules and daughter ions for 307 
identification in complex matrices. Some of these instruments such as QTOF and 308 
Orbitrap have the ability to acquire both qualitative and quantitative information from 309 
samples in one injection and thus chemicals of interest can be retrospectively identify 310 
in these samples. Once the spectra are obtained, there is no need for reanalysing the 311 
sample. This is particularly useful for emerging drugs or pollutants where the 312 
analytical chemists usually have to catch-up to those producing the chemicals. In the 313 
future, standardised configurations could be implemented for routine illicit drug 314 
consumption monitoring while customised configuration will play an important role 315 
in the expanding WWA applications. 316 
2.6 Back estimation of consumption/exposure data  317 
The estimation of illicit drug consumption (IDC) in the population is carried out by 318 
using the equation below (Zuccato et al., 2008): 319 
IDC (mg/person/day) =  େ୧∗୊∗
౎౟ 
ు౟
௉  320 
 321 
Where Ci is the concentration of a given drug residue i (parent drug or metabolite) 322 
measured in raw sewage samples (mg/L), F is the total flow during the sampling 323 
period (L, 24 hours), P is the number of people in the catchment, Ri is the ratio of 324 
molar mass of parent drug to its metabolite and Ei is the average excretion rate of a 325 
drug residue i. 326 
While Ci, F and Ri can be measured readily in the laboratory or at the STP, estimating 327 
the values of P and Ei is more challenging. Ei can be estimated through meta-analysis 328 
of clinical data (Khan and Nicell, 2011). Meanwhile, estimation of population size 329 
could be performed by using resources like census data, STP design capacity, or using 330 
wastewater parameters such as BOD, COD, total phosphorus, total nitrogen (van 331 
Nuijs et al., 2011b). O’Brien et al used a combination of 14 chemical markers of 332 
population size (most of them pharmaceuticals) to estimate the population size using a 333 
Bayesian inference model (O'Brien et al., 2014). Chen et al evaluated seven potential 334 
population biomarkers and found that 5-hydroxyindoleacetic acid and cotinine could 335 
potentially be used as biomarkers for population estimation (Chen et al., 2014). There 336 
are also attempts to evaluate real-time population size by analysing mobile phone 337 
signals in the catchment area which could also be applied for population estimation 338 
(Ran et al., 2013).  339 
It should be noted that there may be some licit sources of biomarkers used to estimate 340 
illicit drugs (e.g. morphine can be generated from the consumption of both heroin and 341 
licit codeine) and hence estimates of illicit drug consumption can be affected by this 342 
phenomenon. In such cases, cautious interpretation should be taken. The typical way 343 
to solve this issue is to subtract the average amount of legal medication/pharmaceutics 344 
that are used in the studied population from the total chemical load measured in 345 
wastewater samples. The input load coming from licit source could be better 346 
evaluated by analysing prescription data and wastewater from the hospitals in the 347 
studied catchment. If the input from licit source is significant (e.g. morphine input 348 
from the use of codeine compared to morphine input from heroin), the lack of 349 
accurate data on licit input could render the WWA estimate less valid and thus WWA 350 
should not be used in such case.   351 
For other chemicals, the process of back estimation is similar as long as the necessary 352 
parameters are available (especially Ei and P). Some chemicals may also come from 353 
other sources such as dumping parent compounds into the sewer which should be 354 
taken into account when interpreting the estimated values. 355 
2.7 Uncertainties and Limitations 356 
Uncertainties may occur in every step from sampling to back-calculation in WWA 357 
studies. Evaluations about uncertainties related to the whole procedure and also 358 
individual aspects have been performed in previous studies. Castiglioni et al 359 
(Castiglioni et al., 2013) evaluated uncertainties associated with all the steps 360 
commonly used in WWA with optimized experimental parameters for each step 361 
defined. Plósz et al. (2013) investigated the biotransformation kinetics and sorption of 362 
cocaine and its metabolites. Factors influencing the estimation of cocaine in sewage 363 
with WWA have been evaluated. Results show that omitting in-pipe bio-364 
transformation affects the accuracy of back-calculated cocaine use estimates. In 365 
addition, ex-vivo biotransformation of target compounds should be considered during  366 
back calculation (Plo´sz et al., 2013). van Nuijs et al. evaluated the stability of nine 367 
illicit drugs and metabolites in samples collected from wastewater influent. The 368 
results suggest that it is quite important to take the compounds stability into account 369 
when dealing with drugs that show significant biotransformation in sewage (van Nuijs 370 
et al., 2012).   371 
3 Applicability in China 372 
3.1 Research related to wastewater in China 373 
China has the largest population size (1.4 billion) in the world. The total sewage 374 
created across the country is estimated as high as 280 billion litres per day 375 
(calculation based on 200 L per capita per day), and most of the populated areas are 376 
sewered and connected to STPs. WWA could thus be used in the evaluation of illicit 377 
drug consumption as well as alcohol, tobacco (Reid et al., 2011) and other chemicals 378 
which are closely related to public health and social sustainability.  379 
Recently a small number of WWA studies were conducted in China for estimating 380 
illicit drug consumption. Lai et al. utilised WWA in Hong Kong in 2011 to evaluate 381 
daily and diurnal patterns of illicit drug consumption in the megacity (Lai et al., 2013). 382 
Khan et al applied WWA in mainland China for the first time to monitor the 383 
consumption of 14 illicit drugs in 4 megacities with samples from 9 STPs covering 384 
approximately 11.4 million inhabitants. The results demonstrate that China has 385 
different drug consumption patterns to European countries. Even within China, the 386 
difference in drug use between the north and south could be observed (Khan et al., 387 
2014). It is proposed that licit manufacture of drugs is more stringent and thus 388 
distinguishing licit from illicit sources of drugs may be possible by further research on 389 
isomer production ratios of the parent compounds and conducting chiral analysis of 390 
wastewater samples. This could potentially lead to monitoring drug manufacture, 391 
formulation, distribution and consumption (Daughton, 2011). 392 
Several review articles (Liu et al., 2009; Liu, 2005; Nie et al., 2011; Xie et al., 2004; 393 
Zhou et al., 2007) have presented a range of research on persistent organic pollutants 394 
(POPs) and emerging pollutants such as pharmaceuticals and personal care products 395 
(PPCPs) in the aquatic environment, particularly in regards towastewater and how to 396 
better manage these chemicals. The articles cover studies on the occurrence of POPs 397 
and PPCPs in STPs (Fan et al., 2011; Zhao et al., 2011), pollutants removal 398 
mechanism in STPs (Jiao et al., 2012), fate and degradation of certain group of POPs 399 
or PPCPs particularly in regard to river water (Lian and Liu, 2013; Liu, 2011; Zhang, 400 
2013), development and optimization of analytical method to qualitatively and 401 
quantitatively determine pollutants in various matrices (Chen et al., 2011; Yuan et al., 402 
2013). However, most studies work ‘downstream’ focusing on environmental 403 
outcomes rather than ‘upstream’ which could provide the ability to evaluate human 404 
exposure and the associated health risks. 405 
3.2 Drug consumption and control in China 406 
Illicit drug abuse in China can be traced back to the 1760s during the Qing dynasty. 407 
The number of drug users in China increased dramatically after the Opium War. Issue 408 
of drug abuse re-emerged in the last two decades which is mainly attributed to global 409 
drug trafficking activities during the implementation of governmental reform and the 410 
open-door policies of the late 1980s (Lu et al., 2008; Qian et al., 2006). Evidence has 411 
shown that over the past decade cocaine and other illicit drug abuse has increased in 412 
East and Southeast Asia. The Ministry of Public Security in China estimates that there 413 
are currently more than two million illicit drug users in China (Xinhua News, 2013). 414 
Also, cocaine seizures in mainland China and Hong Kong increased from 415 
approximately 600,000 kg in 2010 to 800,000 kg in 2011 (UNODC, 2013).  416 
Illicit drug consumption has caused significant consequences for human health and 417 
social stability. In response the Chinese government monitors illicit drug prevalence 418 
and control. However, during the past decade the number of people abusing drugs has 419 
increased significantly and younger generations have become victims of drug 420 
addiction. Synthetic psychotropic drugs (like methamphetamine) prevail among drug 421 
consumers. This situation requires the authorities to design effective policies to 422 
control drug abuse as well as monitoring the effectiveness of these policies. 423 
The ability of WWA to measure near real-time consumption of drugs can assist 424 
authorities in assessing the impact of the strategies they’ve adopted and thus better 425 
manage the situation. In order to develop and implement effective anti-drug strategies, 426 
authorities need information about temporal and geographical patterns of illicit drug 427 
consumption. Wastewater analysis could provide continuous and objective illicit drug 428 
consumption information to the relevant authorities. 429 
3.3 Overview of sewage treatment plants and analytical laboratory capabilities in 430 
China  431 
There are more than 3,000 domestic STPs in China covering most densely populated 432 
areas. The number of STPs is still rapidly increasing with substantial investment from 433 
the Chinese government to reduce environmental impacts. Capacity of these plants 434 
range from less than 10 ML/day to more than 1,000 ML/day. Population size served 435 
differs from a few thousand to hundreds of thousands. Most STPs have online 436 
monitoring of flow, pH, COD and ammonia using auto-samplers and nearly all of 437 
these plants take regular samples for compliance purposes  which may make it easier 438 
to get samples for WWA applications. Therefore, WWA could potentially capture 439 
chemical consumption and/or exposure for a variety of population sizes with 440 
considerably small effort and cost compared with traditional surveys. 441 
China has strong anytical chemistry capabilities with hundreds of research centres and 442 
laboratories located across the country equipped with state of the art analytical 443 
instruments. There are more than 200 laboratories equipped with LC-MS/MS 444 
instruments in various configurations and thus have sufficient analytical abilities to 445 
apply WWA at the national level. Chen et al. (2011) developed a paper strip 446 
extraction ultra-performance liquid chromatography tandem mass spectrometry (PSE-447 
UPLC-MS/MS) method to determine 9 PPCPs in sewage sludge. With further 448 
optimization, this method could be suitable for WWA applications for drug 449 
consumption estimation as well for the measurement of other chemical biomarkers of 450 
consumption and exposure. More recently Yuan et al. (2013) developed and applied 451 
an automated solid phase extraction-high performance liquid chromatography coupled 452 
with electrospray ionization tandem mass spectrometry (ASPE-HPLC-ESI-MS/MS) 453 
method for the quantification of 13 antipsychotics. Eleven of  the thirteen 454 
pharmaceuticals were detected in all 35 samples from one STP. Further studies on 455 
wastewater treatment processes, human health biomarkers and risk assessment could 456 
all benefit through promoting WWA as a feasible and powerful tool for forensic 457 
science, environmental science and epidemiology. 458 
3.4 Potential issues with applying WWA/SCIM in China.  459 
There is no doubt that WWA can provide indicative information for the assessment of 460 
illicit drug consumption. By sampling a variety of STPs and collaboration with the 461 
many advanced research facilities across China, WWA/SCIM could produce valuable 462 
information on current community health which could help define key areas of 463 
concern for both community health and maintaining social justice. However, 464 
investigation and assessment about the study area and objectives should be carried out 465 
before conducting WWA to maximise results. Most STPs constructed before the 466 
1990s receive influent that is a mixture of domestic sewage, industrial wastewater and 467 
stormwater. This may make it more challenging to apply WWA in these areas as the 468 
chemicals in the industrial sewage could interact with the chemicals in domestic 469 
sewage and during rainfall events chemicals of interest may become too diluted to 470 
analyse feasibly.  471 
By comparing concentrations of target chemicals in ambient environmental 472 
monitoring with results of available biomonitoring studies and WWA data, chemical 473 
consumption/exposure models could be developed for pollutants chemicals, 474 
biomarkers of human health, per capita environmental impact and others. One should 475 
also consider that there are huge population relocations during certain national 476 
holidays such as Chinese spring festival. Therefore real-time population estimates of 477 
the studied catchment area is essential to reduce under/overestimation of the per 478 
capita consumption and/or exposure of chemicals. These markers would also require 479 
some form of calibration for the studied catchment such as collecting samples during 480 
a census period.  481 
As most of the STPs in a given city belong to a drainage group governed by the water 482 
resource bureau or the environmental protection agency in the municipal government, 483 
there might be concerns regarding ethical issues related to WWA studies. However, it 484 
was suggested that WWA doesn’t raise major ethical concerns when used for public 485 
health purposes to monitor illicit drug use in large populations (Hall et al., 2012) 486 
although ethical issues may arise from concerns about possible indirect harm from 487 
using WWA in small areas such as prisons or entertainment venues. More effort is 488 
required from the research community, industry and government departments to 489 
promote WWA as an additional tool for illicit drug consumption monitoring. 490 
4 Conclusions 491 
Wastewater analysis is a promising approach to estimate illicit drug consumption and 492 
consumption/exposure of other chemicals of concern at the population level. Our 493 
review suggests that WWA could be a very useful tool in China. It could provide a 494 
relatively easy approach for China to monitor drug consumption and potentially drug 495 
trafficking and manufacturing. Early adoption of WWA/SCIM and archiving samples 496 
would allow China to both make assessments using the current knowledge, as well as 497 
create a sample bank that archives and allows reassessment of samples once analytical 498 
methods are developed or new chemicals of interest are identified. Combined with 499 
traditional survey methods, WWA could be a powerful tool to optimize illicit drug 500 
consumption estimates and provide near real-time and objective data for the 501 
development of strategies concerning drugs of abuse. With progress in research on 502 
other WWA biomarkers, the approach will provide useful epidemiological data for 503 
health status including levels of certain diseases in different communities and might 504 
lead to the establishment of new monitoring approaches for population health.  505 
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